Devices › Wearable automated external defibrillator
Device brand name · Wearable automated external defibrillator
Assure Wearable Cardioverter Defibrillator: medical device reports filed with FDA
1,118 reports name it, 2023–2026. Manufacturer given most often on reports: Kestra Medical Technologies. Product code MVK.
- 1,118
- device reports naming the brand
- 0% of all MAUDE reports · about 420 a year
- 730
- reports, 12 months to August 2026
- 146 in the 12 months before
- 96.2%
- classified as malfunction
- 73.1% across the product code
- 3.5%
- classified as death, as reported
- 39 reports · not verified by FDA
FDA's MAUDE database holds 1,118 reports that name the brand "Assure Wearable Cardioverter Defibrillator" (wearable automated external defibrillator), received between November 2023 and August 2026; the manufacturer given most often on reports is Kestra Medical Technologies. Spellings of one product vary from report to report.
730 reports arrived in the 12 months to August 2026, up 400% from 146 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.2%), death (3.5%) and injury (0.4%); across all wearable automated external defibrillator reports (product code MVK) death is recorded in 2.5% and malfunction in 73.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are electrical /electronic property problem (46.2%), inappropriate/inadequate shock/stimulation (39.7%) and failure to power up (10.1%). The patient problems coded most often are shock from patient lead(s), heart failure/congestive heart failure and asystole. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 149,799 reports carrying product code MVK. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Electrical /electronic property probleman electrical or electronic problem | 516 | 46.2% | 0.7% |
| Inappropriate/inadequate shock/stimulation | 444 | 39.7% | 9.1% |
| Failure to power up | 113 | 10.1% | 10.1% |
| Failure to charge | 7 | 0.6% | 2.8% |
| Connection problema connection problem | 2 | 0.2% | 0.4% |
| Display or visual feedback problem | 1 | 0.1% | 1.5% |
| Insufficient device problem information | 1 | 0.1% | 1.1% |
| Material integrity problema problem with the device material | 1 | 0.1% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Shock from patient lead(s) | 70 | 6.3% |
| Heart failure/congestive heart failure | 8 | 0.7% |
| Asystole | 7 | 0.6% |
| Arrhythmia | 3 | 0.3% |
| Atrial flutter | 1 | 0.1% |
| Bradycardiaslow heart rate | 1 | 0.1% |
| Cardiac arrestthe heart stopped | 1 | 0.1% |
| Dyspneashortness of breath | 1 | 0.1% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Assure Wearable Cardioverter Defibrillator | Product code MVK | All MAUDE reports |
|---|---|---|---|
| Reports | 1,118 | 149,799 | 26,136,888 |
| Share of that pool | — | 0.7% | 0% |
| Classified as death, per 1,000 reports | 35 | 25 | 9 |
| Classified as injury | 0.4% | 24.4% | 36.2% |
| Classified as malfunction | 96.2% | 73.1% | 62.3% |
| Filed by the manufacturer | 99.9% | 100% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MVK
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| LifeVest WCD 4000 System | 140,785 | 10,693 | 2.5% |
| Lifevest Wcd 3000 System | 4,109 | 0 | 1.8% |
| Lifevest Wcd 3100 System | 1,500 | 0 | 2.3% |
| LifeVest WCD 5100 System | 1,189 | 1,076 | 1% |
| Lifevest Wcd 4000 Sys | 371 | 0 | 3% |
| Assure Cardiac Recovery System | 208 | 0 | 4.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Assure Wearable Cardioverter Defibrillator reports
How many FDA reports name Assure Wearable Cardioverter Defibrillator?
1,118 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 730 in the latest 12 months.
What kinds of events are reported?
malfunction (96.2%), death (3.5%) and injury (0.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
electrical /electronic property problem (46.2%), inappropriate/inadequate shock/stimulation (39.7%), failure to power up (10.1%), failure to charge (0.6%) and connection problem (0.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.9%) and voluntary reports (0.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Assure Wearable Cardioverter Defibrillator was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.